Back to IMVT
BAKER BROS. ADVISORS LP → IMVT
BAKER BROS. ADVISORS LP IMVT Position History
Immunovant, Inc. • Healthcare
Quarters held
4
Latest value
$93.6M
Q3 2026
Peak value
$209.4M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $138.7M |
| Q1 2026 | $135.6M |
| Q2 2026 | $209.4M |
| Q3 2026 | $93.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $93.6M | 2.77M | — | — |
| Q2 2026 | $209.4M | 5.44M | — | — |
| Q1 2026 | $135.6M | 5.46M | — | — |
| Q4 2025 | $138.7M | 5.46M | — | — |
Other funds holding IMVT
$359.9M
$347.2M
$309.5M
$290.6M
$286.3M
$275.5M
$246.8M